"There's nothing new in that point of view." John Brightling's doctorate in molecular biology came from the University of Virginia, along with his M.D. "It started with a guy named Ned Ludd a few centuries ago. He was afraid that the Industrial Revolution would put an end to the cottage-industry economy in England. And he was right. That economic model was wrecked. But what replaced it was better for the consumer, and that's why we call it progress!" Not surprisingly, John Brightling, a billionaire heading for number two, was holding court before a small crowd of admirers.
"But the complexity-" One of the audience started to object.
"Happens every day-every second, in fact. And so do the things we're trying to conquer. Cancer, for example. No, madam, are you willing to put an end to our work if it means no cure for breast cancer? That disease strikes five percent of the human population worldwide. Cancer is a genetic disease. The key to curing it is in the human genome. And my company is going to find that key! Aging is the same thing. Salk's team at La Jolla found the kill-me gene more than fifteen years ago. If we can find a way to turn it off, then human immortality can be real. Madam - does the idea of living forever in a body of twenty-five years' maturity appeal to you?"
"But what about overcrowding?" The congresswoman's objection was somewhat quieter than her first. It was too vast a thought, too surprisingly posed, to allow an immediate objection.
"One thing at a time. The invention of DDT killed off huge quantities of disease-bearing insects, and that increased populations all over the world, didn't it? Okay, we are a little more crowded now, but who wants to bring the anopheles mosquito back? Is malaria a reasonable method of population control? Nobody here wants to bring war back, right? We used to use that, too, to control populations. We got over it, didn't we? Hell, controlling populations is no big deal. It's called birth control, and the advanced countries have already learned how to do it, and the backward countries can, too, if they have a good reason for doing so. It might take a generation or so," John Brightling mused, "but is there anyone here who would not want to be twenty-five again-with all the things we've learned along the way, of course. It damned well appeals to me!" he went on with a warm smile. With sky-high salaries and promises of stock options, his company had assembled an incredible team of talent to look at that particular gene. The profits that would accrue from its control could hardly be estimated, and the U.S. patent was good for seventeen years! Human immortality, the new Holy Grail for the medical community-and for the first time it was something for serious investigation, not a topic of pulp science-fiction stories.
"You think you can do it?" another congresswoman this one from San Francisco-asked. Women of all sorts found themselves drawn to this man. Money, power, good looks, and good manners made it inevitable.
John Brightling smiled broadly. "Ask me in five years. We know the gene. We need to learn how to turn it off. There's a whole lot of basic science in there we have to uncover, and along the way we hope to discover a lot of very useful things. It's like setting off with Magellan. We aren't sure what we're going to find, but we know it'll all be interesting." No one pointed out that Magellan hadn't made it home from that particular trip.
"And profitable?" a new senator from Wyoming asked.
"That's how our society works, isn't it? We pay people for doing useful work. Is this area useful enough?"